Olodaterol
Back to searchMolecule Structure
Scientific Name
Olodaterol
Description of the Drug
Olodaterol is a long-acting beta2-adrenergic agonist used in the management of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09080
http://www.drugbank.ca/drugs/DB09080
Brand Name(s)
Striverdi respimat
Company Owner(s)
Boehringer Ingelheim Pharmaceuticals Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Beta-2 adrenergic receptor | SINGLE PROTEIN | AGONIST | CHEMBL210 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL560926 | |
DrugBank | DB09080 | |
PubChem: Thomson Pharma | 16684268 | |
PubChem | 11504295 | |
Nikkaji | J3.100.561B | |
DrugCentral | 4814 | |
ChemicalBook | CB52484977 | |
Guide to Pharmacology | 7543 | |
rxnorm | OLODATEROL HYDROCHLORIDE | OLODATEROL |
ChEBI | 82700 | |
ZINC | ZINC000034636383 |